Lymphocyte costimulatory receptors in renal disease and transplantation

Journal of Nephrology

Volumn 15, Issue 1, 2002, Pages 7-16

  Biancone, Luigi ^a   Deambrosis, Ilaria ^a   Camussi, Giovanni ^a  

^a Dipartimento di Medicina Interna   (Italy)

Author keywords

Costimulatory molecules; Lymphocyte; Transplantation

Indexed keywords

B7 ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD48 ANTIGEN; CD5 ANTIGEN; CD5 IMMUNOGLOBULIN FUSION PROTEIN; CD86 ANTIGEN; CYCLOSPORIN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; INDUCIBLE COSTIMULATOR ANTIBODY; INDUCIBLE COSTIMULATOR B7 RELATED PROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; LIGAND; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 2; MYCOPHENOLIC ACID; RANTES; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELL STIMULATION; CELL SURVIVAL; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; EXPERIMENTAL MODEL; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEMBRANOUS GLOMERULONEPHRITIS; MOLECULAR INTERACTION; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD86; AUTOIMMUNE DISEASES; DNA, COMPLEMENTARY; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 0036127876     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
2. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell costimulatory activity
3. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells
4. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
5. Functional CD40 antigen on B cells, dendritic cells and fibroblasts
6. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
7. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice
8. IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro
9. Expression of functional CD40 by vascular endothelial cells
10. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signalling in atherosclerosis
11. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40
12. Induction of human IgE synthesis in B cells by mast cells and basophils
13. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
14. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
15. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction
16. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
17. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
18. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
19. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2
20. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
21. CTLA-4 is a second receptor for the B cell activation antigen B7
22. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice
23. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
24. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement
25. Stimulatory effects of b7-related protein-1 on cellular and humoral immune responses in mice
26. T-cell co-stimulation through B7RP-1 and ICOS
27. ICOS is critical for CD40-mediated antibody class switching
28. Cutting edge: Critical role of inducible costimulator in germinal center reactions
29. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection
30. CD2/LFA3 ligation induces phospholipase-C-γ-1-tyrosine phosphorylation and regulates CD3 signalling
31. Anti-CD2 antibodies induce T cell unresponsiveness in vivo
32. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies
33. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease
34. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes
35. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5
36. The identification and characterization of a ligand for bovine CD5
37. Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis
38. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides
39. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms
40. Immunological function of tubular epithelial cells: The functional implications of CD40 expression
41. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis
42. Treatment of murine lupus with CTLA4Ig
43. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
44. Peripheral blood lymphocytes in SLE-hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells
45. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
46. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease
47. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor
48. Expression of inducible lymphocyte costimulatory molecules in human renal allograft
49. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
50. Long-term survival of xenogenetic pancreatic islet grafts induced by CTLA4lg
51. CTLA4Ig gene transfer prolongs survival and donor-specific tolerance in renal allograft
52. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction
53. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway
54. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
55. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
56. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
57. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: A role for CD40 signalling in plaque rupture?
58. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
59. Anti-CD154 monoclonal antibody and thromboembolism
60. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
61. Activation of CD40 favours the growth and vascularization of Kaposi's sarcoma
62. Targeting signal one through CD45RB synergyzes with CD40 ligand blockade and promotes long-term engraftment and tolerance in stringent transplant models
63. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection
64. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
65. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: Differential role of B7-1 in initiation versus progression of graft arteriosclerosis